Our study provides novel insights into how loss of CMC4 and FUNDC2 contributes to dysregulation of apoptosis, inflammatory response, and HH and demonstrates the effectiveness of RNA-seq as a way to characterize gene function as part of understanding gene dosage in genetic disorders. This evidence concerns the gene FUNDC2 and hereditary disease.